Fred Hutchinson Cancer Center

‘I can’t remember the last time I saw someone with bad gut GVHD’: BMT expert reflects ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...
Fred Hutchinson Cancer Center

Scientists see foam as starting point of a path to bedside gene therapy

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
Fred Hutchinson Cancer Center

Washington Research Foundation awards $5.2M to establish new clinical trials program

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...
Fred Hutchinson Cancer Center

Honoring years of service at Fred Hutch

On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...
Fred Hutch

Scott Nicholas Furlan, MD

Affiliate Professor, Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch Affiliate Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred ...
Fred Hutchinson Cancer Center

Powerful purpose: Fred Hutch Obliteride raises $9.2M for cancer research

Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...